Picture of Revelation Biosciences logo

REVB — Revelation Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Revelation Biosciences Inc Reports Quarterly Loss Per Share Of $1.77

March 30 (Reuters) - Revelation Biosciences Inc
 REVB.O :
    * REVELATION BIOSCIENCES INC. ANNOUNCES FINANCIAL RESULTS
FOR THE
THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2022 AND RECENT
CORPORATE PROGRESS
    * REVELATION BIOSCIENCES INC - BELIEVES THAT ITS CURRENT
CASH AND
CASH EQUIVALENTS ARE SUFFICIENT TO FUND OPERATIONS THROUGH JUNE
OF 2024
    * REVELATION BIOSCIENCES INC- QTRLY LOSS PER SHARE $1.77

Source text for Eikon:  ID:nBw1C5nxha 
Further company coverage:  REVB.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Revelation Biosciences

See all news